Sadan, Ofer <br/><br/>
A novel brain-targeted antioxidant (AD4) attenuates haloperidol-induced abnormal movement in rats: implications for tardive dyskinesia.  [electronic resource] 

 -  Clinical neuropharmacology   
 - 285-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0362-5664 
<br/><br/><label>Standard No.: </label>10.1097/01.wnf.0000191331.54649.e3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylcysteine--analogs & derivatives<br/>Animals<br/>Antioxidants--therapeutic use<br/>Behavior, Animal--drug effects<br/>Brain Chemistry--drug effects<br/>Disease Models, Animal<br/>Drug Interactions<br/>Dyskinesia, Drug-Induced--drug therapy<br/>Dyskinesias--drug therapy<br/>Exploratory Behavior--drug effects<br/>Female<br/>Haloperidol<br/>Lipid Peroxidation--drug effects<br/>Oxidation-Reduction--drug effects<br/>Rats<br/>Rats, Wistar<br/>Thiobarbituric Acid Reactive Substances--metabolism